Celsion   Report issue

For profit Phase 2 Phase 3
Founded: Lawrenceville NJ United States (2000)
Status: No NME R&D (2000)

Organization Overview

First Clinical Trial
2001
NCT00036985
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Celsion | Celsus Therapeutics PLC | Imunon